Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMirati Therapeut Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Mirati Therapeut Earnings Date And Information
Mirati Therapeut last posted its earnings results on Tuesday, February 27th, 2024. The company reported $-3.51 earnings per share for the quarter, missing analysts' consensus estimates of $-2.66 by $0.85. The company had revenue of 16.40 M for the quarter and had revenue of 12.44 M for the year. Mirati Therapeut has generated $-13 earnings per share over the last year ($-13.18 diluted earnings per share) and currently has a price-to-earnings ratio of -4.46. Mirati Therapeut has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Mirati Therapeut Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2023 | Q3 2023 | -$2.92 | -$2.49 | 0.43 | $19.42 M | $16.40 M |
| 08/08/2023 | Q2 2023 | -$3.23 | -$3.04 | 0.19 | $13.51 M | $13.69 M |
| 05/09/2023 | Q1 2023 | -$3.47 | -$3.02 | 0.45 | $4.78 M | $7.17 M |
| 02/28/2023 | Q4 2022 | -$3.74 | -$3.51 | 0.23 | $1.32 M | $934.00 K |
| 11/08/2022 | Q3 2022 | -$3.46 | -$3.09 | 0.37 | $12.42 M | $5.43 M |
| 08/03/2022 | Q2 2022 | -$3.53 | -$3.18 | 0.35 | $340.00 K | $5.36 M |
| 05/04/2022 | Q1 2022 | -$3.37 | -$3.48 | -0.11 | $727.28 K | $709.00 K |
| 02/28/2022 | Q4 2021 | -$3.01 | -$3.73 | -0.72 | $1.41 M | $299.00 K |
| 11/08/2021 | Q3 2021 | -$2.87 | -$1.55 | 1.32 | $13.28 M | $71.79 M |
| 08/05/2021 | Q2 2021 | -$2.41 | -$3.23 | -0.82 | $6.62 M | $0 |
| 05/06/2021 | Q1 2021 | -$2.13 | -$2.67 | -0.54 | $140.00 K | $0 |
| 02/25/2021 | Q4 2020 | -$2.28 | -$2.09 | 0.19 | $270.00 K | $1.71 M |
| 11/04/2020 | Q3 2020 | -$2.04 | -$1.98 | 0.06 | $11.48 M | $11.42 M |
| 08/06/2020 | Q2 2020 | -$2.10 | -$1.85 | 0.25 | N/A | $0 |
| 05/07/2020 | Q1 2020 | -$1.65 | -$2.02 | -0.37 | $219.42 K | $267.00 K |
| 02/26/2020 | Q4 2019 | N/A | -$1.83 | N/A | $413.90 K | $526.00 K |
| 11/04/2019 | Q3 2019 | -$1.27 | -$1.38 | -0.11 | $894.93 K | $988.00 K |
| 08/05/2019 | Q2 2019 | -$1.21 | -$1.26 | -0.05 | $549.52 K | $577.00 K |
| 04/29/2019 | Q1 2019 | -$0.96 | -$1.17 | -0.21 | $1.03 M | $1.24 M |
| 02/28/2019 | Q4 2018 | -$0.84 | -$0.87 | -0.03 | $3.46 M | $3.46 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mirati Therapeut Earnings: FAQ's
The conference call for Mirati Therapeut's latest earnings report can be listened to online.
The conference call transcript for Mirati Therapeut's latest earnings report can be read online.
Mirati Therapeut (:MRTX) has a recorded annual revenue of $12.44 M.
Mirati Therapeut (:MRTX) has a recorded net income of $-740,867,000.Mirati Therapeut has generated $-13.18 earnings per share over the last four quarters.
Mirati Therapeut (:MRTX) has a price-to-earnings ratio of -4.46 and price/earnings-to-growth ratio is -0.39.